Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 994 entries
View as:

Estimation of Off-Label Use of XGEVA® (Denosumab) Using Population-Based Databases in Denmark

Phase: N/A Priority: Normal
NCT ID: NCT02066805 Org: User:
Start: 01/31/14 End: 02/28/15 Due: 02/28/16

A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01999335 Org: User:
Start: 07/30/14 End: 04/25/19 Due: 04/25/20

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.

Phase: N/A Priority: Normal
NCT ID: NCT00330759 Org: User:
Start: 06/01/06 End: 10/01/11 Due: 10/01/12

A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT06389578 Org: User:
Start: 07/14/22 End: 09/12/23 Due: 09/12/24

E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events

Phase: N/A Priority: Normal
NCT ID: NCT00345839 Org: User:
Start: 08/22/06 End: 04/10/12 Due: 04/10/13

Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00041665 Org: User:
Start: - End: - Due: -

Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01080391 Org: User:
Start: 07/14/10 End: 12/05/17 Due: 12/05/18

Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006215 Org: User:
Start: 10/31/99 End: - Due: -

A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT06214481 Org: User:
Start: 01/23/24 End: 05/27/24 Due: 05/27/25

Effect of Panitumumab on the Pharmacokinetics of Irinotecan

Phase: N/A Priority: Normal
NCT ID: NCT00563316 Org: User:
Start: 03/31/08 End: 06/30/10 Due: 06/30/11

AMG 761 in Adults With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01514981 Org: User:
Start: 12/31/11 End: 02/28/14 Due: 02/28/15

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01493518 Org: User:
Start: 11/30/11 End: 06/30/13 Due: 06/30/14

Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.

Phase: N/A Priority: Normal
NCT ID: NCT01813721 Org: User:
Start: 12/31/12 End: 12/31/13 Due: 12/31/14

Multiple Ascending Dose Study of AMG 598 in Adults With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT03757130 Org: User:
Start: 11/26/18 End: 12/16/19 Due: 12/16/20

AMG 172 First in Human Study in Patients With Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01497821 Org: User:
Start: 01/31/12 End: 01/31/15 Due: 01/31/16

Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin

Phase: N/A Priority: Normal
NCT ID: NCT00111982 Org: User:
Start: 12/31/03 End: 02/28/06 Due: 02/28/07

Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT04040894 Org: User:
Start: - End: - Due: -

Dose-finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00540384 Org: User:
Start: 07/31/99 End: 06/30/02 Due: 06/30/03

An Interventional Study to Evaluate the Effect of Ivabradine on Exercise Capacity in Heart Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT03619187 Org: User:
Start: 11/02/18 End: 02/19/20 Due: 02/19/21

Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00035620 Org: User:
Start: 04/30/00 End: 04/30/07 Due: 04/30/08

A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT00038298 Org: User:
Start: 04/30/02 End: 05/31/04 Due: 05/31/05

A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)

Phase: N/A Priority: Normal
NCT ID: NCT03600883 Org: User:
Start: 08/27/18 End: 05/30/28 Due: 05/30/29

Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00947544 Org: User:
Start: 03/31/10 End: 08/31/11 Due: 08/31/12

APremilast After FumaRic Acid Ester Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02954081 Org: User:
Start: 01/26/17 End: 08/15/22 Due: 08/15/23

Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training

Phase: N/A Priority: Normal
NCT ID: NCT02085993 Org: User:
Start: 07/31/14 End: 11/30/15 Due: 11/30/16